…or the treatment of the inherited blood disorder beta-thalassemia, which will be initiated in the US in 2013. StemCells Inc. has been awarded up to $20 million to fund preclinical development of its product consisting of purified human neur...
Through its Common Fund the NIH has established the Center for Regenerative Medicine (NIH CRM), to s
IMAGES-002-HOUSE_OVERSIGHT_013483.txt
p.1
View source release ↗